Status: Recruiting
Clinical Trial of CMD63 Chimeric Antigen Receptor T-cell (CAR T-cell) in Children With Acute Lymphoblastic Leukemia (ALL)
A Phase 1 clinical trial to evaluate the safety and early efficacy of Chimeric Antigen Receptor T-cell (CAR T-cell) with IL-7Rα signaling targeting CD19 in children with relapsed and refractory B-cell Acute Lymphoblastic Leukemia (ALL) after complete standard treatments.
Participants needed: 16
Trial details
Phase: Phase 1Age: 1-18Biological sex: AllType: InterventionalSponsor: Chulalongkorn UniversityUpdated: Mar 2, 2026Locations: 3
Eligibility criteria
Participants must have relapsed, or refractory ALL treated with at least one lin... [+11]
Active GVHD that required systemic immunosuppressant with 4 weeks of enrollment [+6]